Development and assessment of a biodegradable solvent cast polyester fabric small-diameter vascular graft

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 6, 2014, Pages 1972-1981

  Melchiorri, Anthony J ^a   Hibino, Narutoshi ^b   Brandes, Zachary R ^a   Jonas, Richard A ^b   Fisher, John P ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

biodegradation; poly(glycolic acid); poly(lactic acid); polycaprolactone; vascular grafts

Indexed keywords

BIODEGRADATION; BIOMECHANICS; LACTIC ACID; MECHANICAL PROPERTIES; POLYCAPROLACTONE; TEXTILE FIBERS;

INTIMAL HYPERPLASIA; POLY LACTIC ACID; POLY(GLYCOLIC ACID); POLYESTER FABRIC; POLYGLYCOLIC ACIDS; SMALL-DIAMETER VASCULAR GRAFTS; SYNTHETIC VASCULAR GRAFT; VASCULAR GRAFTS;

GRAFTS;

BIOMATERIAL; POLY(DEXTRO LEVO CAPROLACTONE CO LACTIC ACID); POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; PEPTIDE-GLY-LEU-AMIDE; POLYCAPROLACTONE-CO-LACTIDE; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BIODEGRADATION; BIOMECHANICS; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; BURST PRESSURE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GRAFT PATENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE MODEL; NONHUMAN; PHYSICAL PARAMETERS; PILOT STUDY; PRESSURE; SURFACE PROPERTY; SUTURE RETENTION STRENGTH; TENSILE STRENGTH; VASCULAR PATENCY; YOUNG MODULUS; ANIMAL; BLOOD VESSEL TRANSPLANTATION; CHEMISTRY; SCID MOUSE; UMBILICAL VEIN ENDOTHELIAL CELL;

ABSORBABLE IMPLANTS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CELL ADHESION; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; MICE; MICE, SCID; POLYESTERS; TENSILE STRENGTH;

EID: 84899414339     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34872     Document Type: Article

References (41)

1. Wang X, Lin P, Yao Q, Chen C,. Development of small-diameter vascular grafts. World J Surg 2007; 31: 682-689.
2. Veith FJ, Moss CM, Sprayregen S, Montefusco C,. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. Surgery 1979; 85: 253-256.
3. Darling RC, Linton RF,. Durability of femoropopliteal reconstructions. Surgery 1972; 123: 472-479.
4. Abbott WM, Callow A, Moore W, Rutherford R, Veith F, Weinberg S,. Evaluation and performance standards for arterial prostheses. J Vasc Surg 1993; 17: 746-756.
5. Zilla P, Bezuidenhout D, Human P,. Prosthetic vascular grafts: Wrong models, wrong questions and no healing. Biomaterials 2007; 28: 5009-5027.
6. Chlupác J, Filová E, Bacáková L,. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res 2009; 58 (suppl 2): S119-S139.
7. Tai NR, Salacinski HJ, Edwards A, Hamilton G, Seifalian AM., Compliance properties of conduits used in vascular reconstruction. Br J Surg 2000; 87: 1516-1524.
8. Reichert V, Addili F, Schmitz-Rixen T,. Changes in biomechanical properties of biological and synthetic prostheses. Khirurgiia 1997: 29-35.
9. Dzau VJ, Gibbons GH,. Vascular remodeling: Mechanisms and implications. J Cardiovasc Pharmacol 1993; 21 (Suppl 1): S1-S5.
10. Humphrey JD,. Vascular adaptation and mechanical homeostasis at tissue, cellular, and sub-cellular levels. Cell Biochem Biophys 2008; 50: 53-78.
11. Yokota T, Ichikawa H, Matsumiya G, Kuratani T, Sakaguchi T, Iwai S, Shirakawa Y, Torikai K, Saito A, Uchimura E, Kawaguchi N, Matsuura N, Sawa Y, In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding. J Thorac Cardiovasc Surg 2008; 136: 900-907.
12. Haruguchi H, Teraoka S,. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J Artif Organs 2003; 6: 227-235.
13. Patel SD, Waltham M, Wadoodi A, Burnand KG, Smith A,. The role of endothelial cells and their progenitors in intimal hyperplasia. Ther Adv Cardiovasc Dis 2010; 4: 129-141.
14. Rubanyi GM,. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993; 22 (suppl. 4): S1-S14.
15. Van Hinsbergh VWM,. The endothelium: Vascular control of haemostasis. Eur J Obstet Gynecol Reprod Biol 2001; 95: 198-201.
16. Zhang WJ, Liu W, Cui L, Cao Y,. Tissue engineering of blood vessel. J Cell Mol Med 2007; 11: 945-957.
17. Melchiorri AJ, Hibino N, Fisher JP,. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev 2013; 19: 292-307.
18. Kaihara S, Matsumura S, Mikos AG, Fisher JP,. Synthesis of poly(l-lactide) and polyglycolide by ring-opening polymerization. Nat Protoc 2007; 2: 2767-2771.
19. Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, Tellides G, Sinusas AJ, Pober JS, Saltzman WM, Kyriakides TR, Breuer CK,. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 2008; 29: 1454-1463.
20. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T,. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010; 139: 431-436.
21. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H,. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129: 1330-1338.
22. Falco EE, Coates EE, Li E, Roth JS, Fisher JP,. Fabrication and characterization of porous EH scaffolds and EH-PEG bilayers. J Biomed Mater Res Part A 2011; 97A: 264-271.
23. Fisher JP, Holland TA, Dean D, Mikos AG,. Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part II. In vitro degradation. Biomacromolecules 2003; 4: 1335-1342.
24. Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao Da, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK,. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA 2010; 107: 4669-4674.
25. Sell SA, McClure MJ, Barnes CP, Knapp DC, Walpoth BH, Simpson DG, Bowlin GL,. Electrospun polydioxanone-elastin blends: Potential for bioresorbable vascular grafts. Biomed Mater 2006; 1: 72-80.
26. Han DW, Park YH, Kim JK, Jung TG, Lee KY, Hyon SH, Park JC,. Long-term preservation of human saphenous vein by green tea polyphenol under physiological conditions. Tissue Eng 2005; 11: 1054-1064.
27. Lamm P, Juchem G, Milz S, Schuffenhauer M, Reichart B,. Autologous endothelialized vein allograft: A solution in the search for small-caliber grafts in coronary artery bypass graft operations. Circulation 2001; 104 (suppl 1): 1108-1114.
28. L'Heureux N, Pâquet S, Labbé R, Germain L, Auger FA,. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.
29. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NF, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN,. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-365.
30. Ma N, Wang Z, Chen H, Sun Y, Hong H, Sun Q, Yin M, Liu J,. Development of the novel biotube inserting technique for acceleration of thick-walled autologous tissue-engineered vascular grafts fabrication. J Mater Sci Mater Med 2011; 22: 1037-1043.
31. Zhang L, Zhou J, Lu Q, Wei Y, Hu S,. A novel small-diameter vascular graft: In vivo behavior of biodegradable three-layered tubular scaffolds. Biotechnol Bioeng 2008; 99: 1007-1015.
32. Van Der Giessen WJ, Lincoff AM, Schwartz RS, Van Beusekom HM, Serruys PW, Holmes DR, Ellis SG, Topol EJ,. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-1697.
33. Athanasiou KA, Niederauer GG, Agrawal CM,. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
34. Hinokiyama K, Valen G, Tokuno S, Vedin JB, Vaage J,. Vein graft harvesting induces inflammation and impairs vessel reactivity. Ann Thorac Surg 2006; 82: 1458-1464.
35. Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI,. Vascular inflammation and repair: Implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv 2011; 4: 1057-1066.
36. Hibino N, Yi T, Duncan DR, Rathore A, Dean E, Naito Y, Dardik A, Kyriakides T, Madri J, Pober JS, Shinoka T, Breuer CK,. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 2011; 25: 4253-4263.
37. Zhu S, Malhotra A, Zhang L, Deng S, Zhang T, Freedman NJ, Storms R, Peppel K, Goldschmidt-Clermont PJ, Dong C,. Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice. Atherosclerosis 2010; 212: 63-69.
38. Nelson GN, Mirensky T, Brennan MP, Roh JD, Yi T, Wang Y, Breuer Ck,. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: Preliminary findings. Arch Surg 2008; 143: 488-494.
39. Goyal A, Wang Y, Su H, Dobrucki LW, Brennan M, Fong P, Dardik A, Tellides G, Sinusas A, Pober JS, Saltzman WM, Breuer CK,. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. J Pediatr Surg 2006; 41: 787-791.
40. Mirensky TL, Nelson GN, Brennan MP, Roh JD, Hibino N, Yi T, Shinoka T, Breuer CK,. Tissue-engineered arterial grafts: Long-term results after implantation in a small animal model. J Pediatr Surg 2009; 44: 1127-1132; discussion 1132-1133.
41. Zheng L, Gibson TF, Schechner JS, Pober JS, Bothwell ALM,. Bcl-2 transduction protects human endothelial cell synthetic microvessel grafts from allogeneic T cells in vivo. J Immunol 2004; 173: 3020-3026.